Gene G. Kinney - 27 Jul 2022 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role: President and CEO
Signature: /s/ Michael Malecek, as Attorney in Fact for Gene G. Kinney
Issuer symbol: PRTA
Transactions as of: 27 Jul 2022
Net transactions value: -$9,622
Form type: 4
Filing time: 29 Jul 2022, 21:30:31 UTC
Previous filing: 25 Feb 2022
Next filing: 05 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRTA	Ordinary Shares, par value $0.01 per share	Options Exercise	$2,410	+376	+2.9%	$6.41^*	13,169	27 Jul 2022	Direct
transaction	PRTA	Ordinary Shares, par value $0.01 per share	Sale	$12,032	-376	-2.9%	$32.00	12,793	27 Jul 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRTA	Stock Option (Right to Buy)	Options Exercise	$0	-376	-0.38%	$0.000000	98,698	27 Jul 2022	Ordinary Shares	376	$6.41	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.
F3	The Reporting Person holds options that give him the right to acquire an aggregate of 2,103,398 shares at exercises prices ranging from $6.41 to $32.45, of which 1,571,938 are currently exercisable, and 531,460 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award.